Oaktree Specialty Lending Corporation Common Stock (OCSL)
Fast GrowerFairStock Score: 50/100 — MIXED
Key Financials
| Current Price | $12.1 |
| Market Cap | $1.1B |
| P/E Ratio | 20.51 |
| ROE | 3.48% |
| Dividend Yield | 12.91% |
| Sector | Financial Services |
Strengths
- Generates $182 million in annual free cash flow (16.4% yield on market cap)
- Healthy net profit margin of 12.0% showing consistent profitability
- Revenue growth of 178.0% demonstrates strong top-line momentum
- Attractive 12.5% dividend yield providing steady income returns
Concerns
- Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of -0.0 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Oaktree Specialty Lending Corporation Common Stock is a micro-cap financial services company valued at $1.1 billion. The business generates $305 million in annual revenue with a 12.0% net margin and $182 million in free cash flow. From a quality standpoint, Oaktree shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -0.0 warrants caution. On valuation, the stock is trading at a premium 34.7x earnings, with trades above its Graham Number with a negative 10% margin. Growth dynamics show revenue growing at 178.0% and profit growth of -22.5%. The 12.5% dividend yield adds an income component for patient holders. Our composite FairStock Score of 50/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Oaktree's 178% revenue growth trajectory could accelerate as it captures additional market share in the financial services sector. With $182 million in annual free cash flow (16.4% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 35x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer